FMRP-LEAN: A HIPAA-Compliant AI-Augmented LIMS Architecture for End-to-End Clinical Assay Workflow Optimization

Imagine you're working in a clinical lab where tracking patient samples and ensuring quality control is crucial for accurate results. Currently, many labs rely on spreadsheets and manual processes, which can lead to delays and errors, especially in complex multi-day assays like measuring Fragile X Messenger Ribonucleoprotein (FMRP). This situation can create what's known as operational risk, where mistakes in data handling or communication can have serious consequences for patient care. The challenges are compounded by the need for compliance with regulations like HIPAA, which governs patient data privacy and security.

To address these issues, FMRP-LEAN offers a structured, AI-augmented Laboratory Information Management System (LIMS) that formalizes the management of biospecimens through a finite-state workflow model. This system not only tracks samples with a unique identifier framework but also integrates automated quality control checks and ensures that all operations comply with governance standards. By deploying this architecture, labs can achieve better visibility into their workflows, reduce the time it takes to reconcile quality control issues, and improve communication among team members. Compared to traditional methods, FMRP-LEAN provides a more secure and efficient way to manage clinical research workflows, ultimately enhancing patient outcomes.

FMRP-LEAN introduces a novel architecture for managing clinical workflows with AI integration.

The deployment results show improved observability and reduced latency, supporting the system's effectiveness.